TG Therapeutics logo

TG Therapeutics

A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases

1

Funding Rounds

$25.0m

Money raised

Overview

A biopharmaceutical company developing treatments for B-cell malignancies and autoimmune diseases

Funding series

Funding Series Analysis

The company TG Therapeutics has raised a total of $25m in funding over 1 rounds.

Key Insights:

  • TG Therapeutics Series A round: $25m
TG Therapeutics logo
TG Therapeutics Series A round $25m